Ontology highlight
ABSTRACT:
SUBMITTER: Catenacci DV
PROVIDER: S-EPMC3065981 | biostudies-other | 2011 Apr
REPOSITORIES: biostudies-other
Catenacci Daniel V T DV Kozloff Mark M Kindler Hedy L HL Polite Blase B
Seminars in oncology 20110401 2
Colon cancer (CC) therapies have improved patient outcomes significantly over the last decades in both the adjuvant and metastatic settings. With the introduction of a number of novel agents, both traditional chemotherapies and biologically targeted agents, the need to identify subgroups that are likely and not likely to respond to a particular treatment regimen is paramount. This will allow patients who are likely to benefit to receive optimal care, while sparing those unlikely to benefit from ...[more]